A Multifaceted Hypnosis Smoking-Cessation Program: Enhancing Motivation and Goal Attainment

The International Journal of Clinical and Experimental Hypnosis
Joseph P Green, Steven Jay Lynn

Abstract

Smoking cessation remains a major health priority. Despite public campaigns against smoking and widespread availability of smoking-cessation treatments, many people continue to smoke. The authors argue that the "problem of motivation," that is, suboptimal or fluctuating motivation to resist smoking urges and to comply with the demands of treatment, commonly undermines treatment seeking and adherence, appreciably reducing the success rates of smoking-cessation programs. The authors describe the history of the Winning Edge smoking-cessation program and discuss ways to enhance motivation before, during, and after formal treatment. They illustrate how hypnotic suggestions, administered in the context of their program, can promote cognitive, behavioral, and emotional commitment to treatment and enhance motivation to live a smoke-free life.

References

Aug 1, 1992·The Journal of Applied Psychology·C Viswesvaran, F L Schmidt
May 1, 1992·The International Journal of the Addictions·D GinsbergM Rosinski
Apr 1, 1988·The International Journal of Clinical and Experimental Hypnosis·V Neufeld, S J Lynn
Jan 1, 1986·Journal of Personality and Social Psychology·J R CouncilL P Hafner
Nov 1, 1996·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·V MurgraffK Phillips
Jan 21, 2000·Behavior Modification·D Cervone
Apr 19, 2000·The International Journal of Clinical and Experimental Hypnosis·J P Green, S J Lynn
Sep 30, 2000·The International Journal of Clinical and Experimental Hypnosis·K AhijevychN Nedilsky
Jul 4, 2001·Clinical Psychology Review·J S AbramowitzG P Street
Aug 15, 2003·Journal of Personality and Social Psychology·James J Gross, Oliver P John
Oct 1, 2003·Journal of Consulting and Clinical Psychology·Paul C AmrheinLaura Fulcher
Feb 11, 2004·The International Journal of Clinical and Experimental Hypnosis·Gary R Elkins, M Hasan Rajab
Sep 4, 2004·Addictive Behaviors·David J KavanaghJon May
Mar 18, 2005·Substance Use & Misuse·Nancy Amodei, R J Lamb
Apr 27, 2005·Preventive Medicine·Cheryl OnckenCarolyn M Mazure
Aug 9, 2005·Personality and Social Psychology Review : an Official Journal of the Society for Personality and Social Psychology, Inc·Paula M NiedenthalFrançois Ric
Nov 3, 2005·International Journal of Behavioral Medicine·Thuy BoardmanJasjit S Ahluwalia
Apr 4, 2006·The International Journal of Clinical and Experimental Hypnosis·Joseph P GreenGuy H Montgomery
Apr 18, 2006·Patient Education and Counseling·Sylvia MayHayden McRobbie
May 3, 2006·Journal of Consulting and Clinical Psychology·Leonard S MillingGina M Carosella
Jun 13, 2006·The International Journal of Clinical and Experimental Hypnosis·Gary ElkinsTeresa Cook
Nov 30, 2006·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Amit SoodSusanna R Stevens
Sep 19, 2007·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Steven J LashRonnie D Horner
Feb 6, 2008·The American Journal of Clinical Hypnosis·Joseph P GreenGuy H Montgomery
Jun 24, 2008·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Timothy P CarmodyKevin Delucchi
Oct 30, 2008·Journal of Health Communication·Shaojun MaFrances A Stillman
Sep 17, 2009·Health Policy·Philip Tønnesen
Sep 11, 2009·The American Psychologist·William R Miller, Gary S Rose
Dec 9, 2009·Journal of Consulting and Clinical Psychology·Theresa B MoyersJ Scott Tonigan
Feb 26, 2010·The International Journal of Clinical and Experimental Hypnosis·Michael R NashJacob J Levy
Mar 2, 2010·The American Journal of Clinical Hypnosis·Steven Jay LynnColleen Cleere
Sep 15, 2010·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Mark Conner, Andrea R Higgins
Oct 15, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Ron BorlandGeoffrey T Fong
Mar 5, 2011·Journal of Medical Internet Research·Robyn WhittakerPenny Salmon
Jun 15, 2011·American Journal of Preventive Medicine·Christi A PattenShu-Hong Zhu
Apr 11, 2012·Consciousness and Cognition·Inge Schweiger GalloPeter M Gollwitzer
Feb 23, 2013·The International Journal of Clinical and Experimental Hypnosis·Etzel CardeñaFredrik Hejdström
Mar 14, 2013·JAMA : the Journal of the American Medical Association·Carole ClairJames B Meigs
Jun 4, 2013·The Cochrane Database of Systematic Reviews·Lindsay F SteadTim Lancaster
Sep 5, 2013·Psychotherapy·Henny A Westra, Adi Aviram
Mar 3, 2015·The American Psychologist·Bonnie SpringJeffery D Fisher
Nov 11, 2016·MMWR. Morbidity and Mortality Weekly Report·Ahmed JamalCorinne M Graffunder
Nov 20, 2016·Vascular Medicine·Elizabeth V Ratchford, Natalie S Evans
Mar 17, 2017·The American Journal of Clinical Hypnosis·Steven Jay LynnJoseph P Green

❮ Previous
Next ❯

Citations

May 5, 2020·The International Journal of Clinical and Experimental Hypnosis·Olivia J GreenPatrick J Carroll

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved